NordICC Colonoscopy Trial Results Fall Short of Expectations
scienceofficial.org
A Lancet correspondence says the NordICC trial's modest colorectal cancer reductions must be seen in the context of widespread colonoscopy use during the study period.

A correspondence in The Lancet argues that the NordICC trial’s modest reductions in colorectal cancer incidence and mortality must be understood in the context of widespread colonoscopy use during the study period.

3